Delayed administration of elezanumab, a human anti-RGMa neutralizing monoclonal antibody, promotes recovery following cervical spinal cord injury
Titel:
Delayed administration of elezanumab, a human anti-RGMa neutralizing monoclonal antibody, promotes recovery following cervical spinal cord injury
Auteur:
Mothe, Andrea J. Jacobson, Peer B. Caprelli, Mitchell Ulndreaj, Antigona Rahemipour, Radmehr Huang, Lili Monnier, Philippe P. Fehlings, Michael G. Tator, Charles H.